Toxoplasma Gondii Found in Cerebrospinal Fluid of COVID-19 Positive Patient with Systemic Lupus Erythematosus
Nikhil Prasad Fact checked by:Thailand Medical News Team Mar 08, 2025 1 month, 5 days, 10 hours, 46 minutes ago
Medical News: A recent medical case has drawn attention to the severe neurological complications that can arise when systemic lupus erythematosus (SLE) patients contract toxoplasmosis, especially when immunosuppressive treatments and concurrent infections are involved. Researchers from the First People’s Hospital of Yunnan Province and the Affiliated Hospital of Kunming University of Science and Technology in China have documented a rare case in which Toxoplasma gondii, the parasite responsible for toxoplasmosis, was detected in the cerebrospinal fluid of an SLE patient who also tested positive for COVID-19. Their findings highlight the importance of early and accurate diagnosis in immunocompromised patients presenting with neurological symptoms.
Toxoplasma Gondii Found in Cerebrospinal Fluid of COVID-19 Positive Patient with Systemic Lupus Erythematosus
Understanding Toxoplasmosis in Immunocompromised Patients
Toxoplasmosis is caused by the intracellular parasite Toxoplasma gondii, which infects nearly one-third of the global population. Most healthy individuals experience only mild flu-like symptoms or remain asymptomatic. However, in immunocompromised individuals, the parasite can reactivate, leading to severe conditions such as toxoplasmic encephalopathy. This
Medical News report sheds light on how latent infections can turn into life-threatening conditions when combined with diseases like SLE and COVID-19.
Neurotoxoplasmosis, also known as toxoplasmic encephalitis (TE), is a severe manifestation of toxoplasmosis that occurs primarily in individuals with weakened immune systems, such as those with HIV/AIDS. However, this case illustrates that SLE patients undergoing immunosuppressive treatment are also at significant risk. The misdiagnosis of TE as lupus-related neurological complications can delay proper treatment and lead to fatal outcomes.
Case Report
The case involved a 21-year-old female with a two-year history of SLE who had been on long-term immunosuppressive therapy, including methylprednisolone, mycophenolate mofetil, and tacrolimus. Her condition worsened over time, with symptoms including urinary incontinence, severe headaches, and episodes of unconsciousness. Initially, lupus cerebritis was suspected, and she was treated with a combination of corticosteroids and immunosuppressive medications.
Her condition deteriorated further when she developed a high fever and tested positive for COVID-19. Despite receiving antiviral therapy, her neurological symptoms worsened, leading to seizures, loss of consciousness, and respiratory distress. A brain MRI revealed multiple abnormalities, raising concerns of acute necrotic encephalopathy, a possible result of COVID-19 or lupus-related complications.
After further testing, cerebrospinal fluid (CSF) analysis revealed elevated white blood cell counts and abnormally high protein levels. However, standard tests for bacterial, fungal, and tuberculosis infections returned negative results. A cytological examination of her CSF confirmed the presence of Toxopla
sma gondii tachyzoites, while serological tests showed high levels of Toxoplasma-specific IgM and IgG antibodies, confirming an active infection.
Key Study Findings
This case report underscores several critical findings:
-Toxoplasma gondii in CSF - The direct detection of Toxoplasma gondii tachyzoites in cerebrospinal fluid is extremely rare in adults. In immunocompromised patients, particularly those with SLE, it is crucial to consider toxoplasmosis as a differential diagnosis for unexplained neurological symptoms.
-SLE and Immunosuppressive Therapy as Risk Factors - The patient’s prolonged use of immunosuppressive drugs significantly weakened her immune defenses, increasing her vulnerability to opportunistic infections like toxoplasmosis.
-Concurrent COVID-19 Infection - The presence of COVID-19 may have exacerbated the patient’s condition by further compromising her immune system, potentially accelerating the reactivation of latent toxoplasmosis.
-Diagnostic Challenges - Toxoplasmic encephalopathy is often misdiagnosed due to its similarity to other neurological disorders associated with SLE, such as neuropsychiatric lupus. This highlights the importance of including Toxoplasma testing in the diagnostic process for SLE patients with unexplained neurological symptoms.
Implications for Diagnosis and Treatment
This case emphasizes the need for early clinical suspicion and comprehensive testing in immunocompromised patients presenting with neurological symptoms.
While serological tests remain the primary method for diagnosing toxoplasmosis, direct detection of parasites in CSF provides the most definitive evidence of infection. Neuroimaging techniques such as MRI can also aid in diagnosis by revealing characteristic brain lesions associated with toxoplasmic encephalitis.
Early and aggressive treatment is crucial for improving patient outcomes. In this case, the patient received a combination of antiparasitic and supportive therapies, but her condition continued to deteriorate, ultimately leading to her discharge in critical condition. This outcome highlights the urgent need for improved diagnostic protocols and timely interventions.
Conclusions
This case study highlights the severe neurological risks posed by toxoplasmosis in immunocompromised individuals, particularly those with systemic lupus erythematosus undergoing immunosuppressive therapy. The reactivation of latent Toxoplasma gondii infections can result in fatal neurological complications if not diagnosed and treated promptly. Given the growing number of immunocompromised patients due to chronic diseases and medical treatments, clinicians must remain vigilant for opportunistic infections, including toxoplasmosis.
Serological tests, PCR, and neuroimaging remain essential tools for diagnosing toxoplasmosis, but direct observation of Toxoplasma gondii in CSF is a rare and definitive diagnostic method. This case underscores the importance of considering toxoplasmic encephalopathy in SLE patients with unexplained neurological symptoms, especially when they have been on long-term immunosuppressive therapy.
As more cases emerge, further research is needed to refine diagnostic techniques and treatment strategies for managing toxoplasmosis in high-risk populations.
The study findings were published in the peer-reviewed journal: BMC Infectious Diseases.
https://link.springer.com/article/10.1186/s12879-025-10630-1
For the latest COVID-19 News, keep on logging to Thailand
Medical News.
Read Also:
https://www.thailandmedical.news/news/study-reveals-possible-link-between-toxoplasma-gondii-infections-and-covid-19
https://www.thailandmedical.news/news/breaking-toxoplasma-gondii-university-of-virginia-study-says-that-about-two-billion-people-have-a-brain-parasite-spread-by-cats-and-contaminated-meat
https://www.thailandmedical.news/news/breaking-canadian-scientists-discover-novel-narnavirus-which-is-pathogenic-to-humans-hiding-inside-the-parasite-toxoplasma-gondii
https://www.thailandmedical.news/pages/thailand_doctors_listings
https://www.thailandmedical.news/pages/thailand_hospital_listings
Share
Tweet
Share
